SynthesisFrontiers in oncology2024

Comparative efficacy and safety of targeted therapy and immunotherapy for HER2-positive breast cancer: a systematic review and network meta-analyses.

Suyu Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.